Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension, June 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 107 articles:
HTML format


 

Single Articles

  1. ERDOGAN E, Cap M, Efe S
    An unusual cause of pulmonary hypertension; partial anomalous pulmonary venous return to coronary sinus detected on transesophageal echocardiography.
    Anatol J Cardiol. 2019;21:E14-E15.
    Abstract    



  2. YAYLALI YT, Basarici I, Kilickiran Avci B, Meric M, et al
    Risk assessment and survival of patients with pulmonary hypertension: Multicenter experience in Turkey.
    Anatol J Cardiol. 2019;21:322-330.
    Abstract    

    Abstract available

  3. CHIOUKH FZ, Monastiri K
    Primary Pulmonary Hypertension Associated with Asymptomatic Methylmalonic Aciduria in a Child.
    J Coll Physicians Surg Pak. 2019;29:S43-S44.
    Abstract    

    Abstract available

  4. ZHU R, Xie X, Wang N, Chen L, et al
    The Th17/Treg imbalance was associated with Ras-GTPase overexpression in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease.
    Immunology. 2019 May 29. doi: 10.1111/imm.13084.
    Abstract    

    Abstract available

  5. FAYED H, Coghlan JG
    Pulmonary Hypertension Associated with Connective Tissue Disease.
    Semin Respir Crit Care Med. 2019;40:173-183.
    Abstract    

    Abstract available

  6. ARAS MA, Psotka MA, De Marco T
    Pulmonary Hypertension Due to Left Heart Disease: an Update.
    Curr Cardiol Rep. 2019;21:62.
    Abstract    

    Abstract available

  7. MCCLENAGHAN C, Woo KV, Nichols CG
    Pulmonary Hypertension and ATP-Sensitive Potassium Channels.
    Hypertension. 2019 May 28:HYPERTENSIONAHA11912992.
    Abstract    



  8. SENTURK B, Akdeniz B, Yilmaz MB, Ozcan Kahraman B, et al
    Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?
    Clin Rheumatol. 2019 May 26. pii: 10.1007/s10067-019-04603.
    Abstract    

    Abstract available

  9. BIGNA JJ, Nansseu JR, Noubiap JJ
    Pulmonary hypertension in the global population of adolescents and adults living with HIV: a systematic review and meta-analysis.
    Sci Rep. 2019;9:7837.
    Abstract    

    Abstract available

  10. DRAGU R, Hardak E, Ohanyan A, Adir Y, et al
    Prognostic value and diagnostic properties of the diastolic pulmonary pressure gradient in patients with pulmonary hypertension and left heart disease.
    Int J Cardiol. 2019 May 13. pii: S0167-5273(18)37508.
    Abstract    

    Abstract available

  11. WEST JD, Chen X, Ping L, Gladson S, et al
    Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension.
    Pulm Circ. 2019 May 24:2045894019856483. doi: 10.1177/2045894019856483.
    Abstract    



  12. VENKATESHVARAN A, Hamade J, Kjellstrom B, Lund LH, et al
    Doppler estimates of pulmonary vascular resistance to phenotype pulmonary hypertension in heart failure.
    Int J Cardiovasc Imaging. 2019 May 23. pii: 10.1007/s10554-019-01591.
    Abstract    

    Abstract available

  13. HANDRA-LUCA A
    Alveolar Septa Muscle: Subclinical Pulmonary Hypertension-Related Change or Malformation?
    J Thorac Oncol. 2019;14:e124-e125.
    Abstract    



  14. MOLANO FRANCO D, Nieto Estrada VH, Gonzalez Garay AG, Marti-Carvajal AJ, et al
    Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.
    Cochrane Database Syst Rev. 2019;4:CD013315.
    Abstract    

    Abstract available

  15. YADAV A, Kumar J
    Seizure in infancy: not the usual suspect.
    BMJ Case Rep. 2019;12.
    Abstract    



  16. MINOMO S, Kitaichi M, Arai T, Matsui H, et al
    Pulmonary Veno-occlusive Disease: A Surgical Lung Biopsy-proven and Autopsied Case Radiologically Mimicking Hypersensitivity Pneumonitis at the Time of a Transbronchial Lung Biopsy.
    Intern Med. 2019;58:955-964.
    Abstract    

    Abstract available

  17. LEVINE AR, Simon MA, Gladwin MT
    Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.
    Trends Cardiovasc Med. 2019;29:207-217.
    Abstract    

    Abstract available

  18. BORDENAVE J, Thuillet R, Tu L, Phan C, et al
    Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Cardiovasc Res. 2019 Jun 7. pii: 5512358. doi: 10.1093.
    Abstract    

    Abstract available

  19. DETWEILER ND, Herbert LM, Garcia SM, Yan S, et al
    Loss of Acid-Sensing Ion Channel 2 Enhances Pulmonary Vascular Resistance and Hypoxic Pulmonary Hypertension.
    J Appl Physiol (1985). 2019 Jun 6. doi: 10.1152/japplphysiol.00894.2018.
    Abstract    

    Abstract available

  20. JOZEFKOWICZ M, Haag DF, Mazzucchelli MT, Salgado G, et al
    Effects and Tolerability of Treprostinil in Neonates with Persistent Pulmonary Hypertension.
    Am J Perinatol. 2019 Jun 5. doi: 10.1055/s-0039-1692182.
    Abstract    

    Abstract available

  21. REIS A, Santos M, Furtado I, Cruz C, et al
    Disability and its clinical correlates in pulmonary hypertension measured through the World Health Organization Disability Assessment Schedule 2.0: a prospective, observational study.
    J Bras Pneumol. 2019;45:e20170355.
    Abstract    

    Abstract available

  22. BORETSKY KR, Casta A
    Pulmonary Hypertension Manifesting as Atrial Arrhythmia in an Anesthetized Child; Diagnosis Using Focused Cardiac Ultrasound (FoCUS).
    Paediatr Anaesth. 2019 Jun 5. doi: 10.1111/pan.13680.
    Abstract    

    Abstract available

  23. KEYMEL S, Papadopoulos G, Minol JP, Blehm A, et al
    Patients with severe aortic stenosis and coexisting pulmonary hypertension treated by transapical transcatheter aortic valve replacement-Is there a need for increased attention?
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28358.
    Abstract    

    Abstract available

  24. NIZNANSKY M, Ambroz D, Prskavec T, Jansa P, et al
    Surgical treatment of chronic thromboembolic pulmonary hypertension.
    Vnitr Lek. 2019;65:353-358.
    Abstract    

    Abstract available

  25. GENTILLE LORENTE DI
    Coconut atrium: a rare entity to cause pulmonary hypertension.
    Eur Heart J. 2019 Jun 4. pii: 5510776. doi: 10.1093.
    Abstract    



  26. SHEN L, Patel JA, Norel X, Moledina S, et al
    Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension.
    Biochem Pharmacol. 2019 May 31. pii: S0006-2952(19)30214.
    Abstract    

    Abstract available

  27. RODRIGUEZ-GONZALEZ M, Benavente-Fernandez I, Castellano-Martinez A, Lechuga-Sancho AM, et al
    NT-proBNP plasma levels as biomarkers for pulmonary hypertension in healthy infants with respiratory syncytial virus infection.
    Biomark Med. 2019 Jun 3. doi: 10.2217/bmm-2018-0348.
    Abstract    

    Abstract available

  28. ROHM I, Grun K, Muller LM, Baz L, et al
    Cellular inflammation in pulmonary hypertension: Detailed analysis of lung and right ventricular tissue, circulating immune cells and effects of a dual endothelin receptor antagonist.
    Clin Hemorheol Microcirc. 2019 May 27. pii: CH180529. doi: 10.3233/CH-180529.
    Abstract    

    Abstract available

  29. KARYOFYLLIS P, Demerouti E, Kabanarou S, Tsiapras D, et al
    An unusual presentation of iatrogenic pulmonary hypertension.
    Hellenic J Cardiol. 2019 May 30. pii: S1109-9666(19)30163.
    Abstract    



  30. WEISS A, Neubauer MC, Yerabolu D, Kojonazarov B, et al
    Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension.
    Nat Commun. 2019;10:2204.
    Abstract    

    Abstract available

  31. DUGGAN E, Puligandla PS
    Respiratory disorders in patients with omphalocele.
    Semin Pediatr Surg. 2019;28:115-117.
    Abstract    

    Abstract available

  32. LIU T, Zou XZ, Huang N, Ge XY, et al
    miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
    Life Sci. 2019;227:64-73.
    Abstract    

    Abstract available

  33. MOHAMED AAA, Hammam N, El Zohri MH, Gheita TA, et al
    Cardiac Manifestations in Systemic Lupus Erythematosus: Clinical Correlates of Subclinical Echocardiographic Features.
    Biomed Res Int. 2019;2019:2437105.
    Abstract    

    Abstract available

  34. OGAWA A, Sakao S, Tanabe N, Matsubara H, et al
    Use of vasodilators for the treatment of pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: A systematic review.
    Respir Investig. 2019;57:183-190.
    Abstract    

    Abstract available

  35. DEL RIO JM, Grecu L, Nicoara A
    Right Ventricular Function in Left Heart Disease.
    Semin Cardiothorac Vasc Anesth. 2019;23:88-107.
    Abstract    

    Abstract available

  36. HUI M, Zhao J, Tian Z, Wang J, et al
    Red blood cell distribution width as a potential predictor of survival of pulmonary arterial hypertension associated with primary Sjogren's syndrome: a retrospective cohort study.
    Clin Rheumatol. 2019;38:477-485.
    Abstract    

    Abstract available

  37. FRIESEN RM, Schafer M, Ivy DD, Abman SH, et al
    Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension.
    Eur Heart J Cardiovasc Imaging. 2019;20:209-217.
    Abstract    

    Abstract available

  38. OCAL S, Portakal O, Ocal A, Demir AU, et al
    Corrigendum to "Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects" [Respir. Med. (2016) 119109-114].
    Respir Med. 2019 Jun 11. pii: S0954-6111(19)30165.
    Abstract    



  39. HOSOKAWA K, Abe K, Tsutsui H
    Use of direct oral anticoagulants prevents increase in pulmonary vascular resistance and incidence of clinical worsening in patients with chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2019;180:43-46.
    Abstract    



  40. GHIO S, Raineri C, Scelsi L, Asanin M, et al
    Pulmonary hypertension and right ventricular remodeling in HFpEF and HFrEF.
    Heart Fail Rev. 2019 Jun 13. pii: 10.1007/s10741-019-09810.
    Abstract    

    Abstract available

  41. STAM K, Cai Z, van der Velde N, van Duin R, et al
    Cardiac remodeling in a swine model of chronic thrombo-embolic pulmonary hypertension- comparison of right vs. left ventricle.
    J Physiol. 2019 Jun 13. doi: 10.1113/JP277896.
    Abstract    

    Abstract available

  42. LUNDGREN J, Radegran G
    [Pulmonary hypertension due to left heart disease - not to be confused with pulmonary arterial hypertension].
    Lakartidningen. 2019;116.
    Abstract    

    Abstract available

  43. ZHANG X, Ye L, Huang Y, Ding X, et al
    The potential role of TRPV1 in pulmonary hypertension: angel or demon?
    Channels (Austin). 2019 Jun 12. doi: 10.1080/19336950.2019.1631106.
    Abstract    

    Abstract available

  44. TIAN H, Fan F, Geng J, Deng J, et al
    Beraprost Upregulates KV Channel Expression and Function via EP4 Receptor in Pulmonary Artery Smooth Muscle Cells Obtained from Rats with Hypoxia-Induced Pulmonary Hypertension.
    J Vasc Res. 2019 Jun 12:1-11. doi: 10.1159/000500424.
    Abstract    

    Abstract available

  45. LIGON RA, Vaiyani D, Deshpande S
    Right ventricular myocardial performance index in pediatric patients with bronchopulmonary dysplasia-related pulmonary hypertension.
    Echocardiography. 2019 Jun 11. doi: 10.1111/echo.14392.
    Abstract    

    Abstract available

  46. KOLMEL S, Hobohm L, Kaberich A, Krieg VJ, et al
    Potential Involvement of Osteopontin in Inflammatory and Fibrotic Processes in Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension.
    Thromb Haemost. 2019 Jun 10. doi: 10.1055/s-0039-1692174.
    Abstract    

    Abstract available

  47. LE T, Makar C, Morway P, Hoftman N, et al
    Pulmonary artery denervation: a novel treatment modality for pulmonary hypertension.
    J Thorac Dis. 2019;11:1094-1096.
    Abstract    



  48. MENE-AFEJUKU TO, Akinlonu A, Dumancas C, Lopez PD, et al
    Relationship between pulmonary hypertension and outcomes among patients with heart failure with reduced ejection fraction.
    Hosp Pract (1995). 2019 Jun 14:1-6. doi: 10.1080/21548331.2019.1628615.
    Abstract    

    Abstract available

  49. VENKATESHVARAN A, Manouras A, Kjellstrom B, Lund LH, et al
    The additive value of echocardiographic pulmonary to left atrial global strain ratio in the diagnosis of pulmonary hypertension.
    Int J Cardiol. 2019 May 31. pii: S0167-5273(18)35980.
    Abstract    

    Abstract available

  50. ONG MS, Abman S, Austin ED, Feinstein JA, et al
    Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry.
    J Pediatr. 2019 Jun 5. pii: S0022-3476(19)30529.
    Abstract    

    Abstract available

  51. ZAFRIR B, Carasso S, Goland S, Zilberman L, et al
    The impact of left ventricle ejection fraction on heart failure patients with pulmonary hypertension.
    Heart Lung. 2019 Jun 5. pii: S0147-9563(18)30632.
    Abstract    

    Abstract available

  52. VEZZOSI T, Schober KE
    Doppler-derived echocardiographic evidence of pulmonary hypertension in cats with left-sided congestive heart failure.
    J Vet Cardiol. 2019;23:58-68.
    Abstract    

    Abstract available

  53. SUDUNAGUNTA S, Green D, Christley R, Dukes-McEwan J, et al
    The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    J Vet Cardiol. 2019;23:21-31.
    Abstract    

    Abstract available

  54. MORITA T, Nakamura K, Osuga T, Morishita K, et al
    Right ventricular function and dyssynchrony measured by echocardiography in dogs with precapillary pulmonary hypertension.
    J Vet Cardiol. 2019;23:1-14.
    Abstract    

    Abstract available

  55. LI Q, Kuang HY, Wu YH, Lu TW, et al
    What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisenmenger syndrome: A systematic review and meta-analysis.
    Medicine (Baltimore). 2019;98:e15632.
    Abstract    

    Abstract available

  56. FERGUSON SK, Pak DI, Hopkins JL, Harral JW, et al
    Pre-clinical assessment of a water-in-fluorocarbon emulsion for the treatment of pulmonary vascular diseases.
    Drug Deliv. 2019;26:147-157.
    Abstract    

    Abstract available

  57. WANG X, Xiao D, Ma C, Zhang L, et al
    The effect of honokiol on pulmonary artery endothelium cell autophagy mediated by cyclophilin A in hypoxic pulmonary arterial hypertension.
    J Pharmacol Sci. 2019;139:158-165.
    Abstract    

    Abstract available

  58. PARDALA A, Lupa M, Chudek J, Kolonko A, et al
    Lung Ultrasound B-lines Occurrence in Relation to Left Ventricular Function and Hydration Status in Hemodialysis Patients.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  59. DEMEROUTI E, Karyofyllis P, Athanassopoulos G, Karatasakis G, et al
    Pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis. Case report and literature review.
    Mult Scler Relat Disord. 2019;28:273-275.
    Abstract    

    Abstract available

  60. AKBAYRAK H, Tekumit H
    Pulmonary thromboendarterectomy in a combined thrombophilia patient.
    Cardiovasc J Afr. 2019;30:e4-e6.
    Abstract    

    Abstract available

  61. WERTHER EVALDSSON A, Ingvarsson A, Smith JG, Radegran G, et al
    Echocardiographic right ventricular strain from multiple apical views is superior for assessment of right ventricular systolic function.
    Clin Physiol Funct Imaging. 2019;39:168-176.
    Abstract    

    Abstract available

  62. ZHU N, Gonzaga-Jauregui C, Welch CL, Ma L, et al
    Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults.
    Circ Genom Precis Med. 2018;11:e001887.
    Abstract    

    Abstract available

  63. FUJISAWA T, Kataoka M, Kawakami T, Isobe S, et al
    Response by Fujisawa et al to Letter Regarding Article, "Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension".
    Circ Cardiovasc Interv. 2018;11:e006244.
    Abstract    



  64. KUEBLER WM, Friedberg MK
    Letter by Kuebler and Friedberg Regarding Article, "Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension".
    Circ Cardiovasc Interv. 2018;11:e006148.
    Abstract    



  65. JIANG X, Du Y, Cheng CY, Denas G, et al
    Antiphospholipid Syndrome in Chronic Thromboembolic Pulmonary Hypertension: A Well-Defined Subgroup of Patients.
    Thromb Haemost. 2019 Jun 21. doi: 10.1055/s-0039-1692428.
    Abstract    

    Abstract available

  66. SINGH I, Rahaghi F, Naeije R, Oliveira R, et al
    EXPRESS: Dynamic Right Ventricular - Pulmonary Arterial Uncoupling During Maximum Incremental Exercise in Exercise Pulmonary Hypertension and Pulmonary Arterial Hypertension.
    Pulm Circ. 2019 Jun 20:2045894019862435. doi: 10.1177/2045894019862435.
    Abstract    



  67. SAAVEDRA H, Toncel C, Delgado V, Borre O, et al
    Reversible pulmonary hypertension and high-output heart failure triggered by pregnancy in a patient with congenital arteriovenous malformation: A case report.
    Obstet Med. 2019;12:97-99.
    Abstract    

    Abstract available

  68. WANG EL, Jia MM, Luo FM, Li T, et al
    Coordination between NADPH oxidase and vascular peroxidase 1 promotes dysfunctions of endothelial progenitor cells in hypoxia-induced pulmonary hypertensive rats.
    Eur J Pharmacol. 2019 Jun 16:172459. doi: 10.1016/j.ejphar.2019.172459.
    Abstract    

    Abstract available

  69. MOHAMED MF, Ali A, Abbas A, Awad MS, et al
    Mean platelet volume as a predictor of pulmonary hypertension in patients with stable COPD.
    Int J Chron Obstruct Pulmon Dis. 2019;14:1099-1108.
    Abstract    

    Abstract available

  70. HASSANPOUR H, Bahadoran S, Neidaripour F, Ehsanifar N, et al
    Brain renin-angiotensin system in broiler chickens with cold-induced pulmonary hypertension.
    Br Poult Sci. 2019 Jun 19. doi: 10.1080/00071668.2019.1632415.
    Abstract    

    Abstract available

  71. HUANG J, Lu W, Ouyang H, Chen Y, et al
    Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the EndMT.
    Am J Respir Cell Mol Biol. 2019 Jun 18. doi: 10.1165/rcmb.2018-0165.
    Abstract    

    Abstract available

  72. LI J, Harnois LJ, Markos B, Roberts KM, et al
    Epoprostenol Delivered via High Flow Nasal Cannula for ICU Subjects with Severe Hypoxemia Comorbid with Pulmonary Hypertension or Right Heart Dysfunction.
    Pharmaceutics. 2019;11.
    Abstract    

    Abstract available

  73. WANG M, Gu S, Liu Y, Yang Y, et al
    miRNA-PDGFRB/HIF1A-lncRNA CTEPHA1 Network Plays Important Roles in the Mechanism of Chronic Thromboembolic Pulmonary Hypertension.
    Int Heart J. 2019 Jun 14. doi: 10.1536.
    Abstract    

    Abstract available

  74. XIAO L, Tong X
    [Advances in molecular mechanism of vascular remodeling in pulmonary arterial hypertension].
    Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019;48:102-110.
    Abstract    

    Abstract available

  75. SILVA AF, Faria-Costa G, Sousa-Nunes F, Santos MF, et al
    Anti-Remodeling Effects of Xanthohumol-Fortified Beer in Pulmonary Arterial Hypertension Mediated by ERK and AKT Inhibition.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  76. TAO W, Sun W, Zhu H, Zhang J, et al
    miR-205-5p suppresses pulmonary vascular smooth muscle cell proliferation by targeting MICAL2-mediated Erk1/2 signaling.
    Microvasc Res. 2019;124:43-50.
    Abstract    

    Abstract available

  77. DEMEROUTI E, Karyofyllis P, Manginas A, Anthi A, et al
    Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol.
    Am J Cardiovasc Drugs. 2019;19:99-105.
    Abstract    

    Abstract available

  78. JIANG R, Liu H, Pudasaini B, Zhang R, et al
    Characteristics of cardiopulmonary exercise testing of patients with borderline mean pulmonary artery pressure.
    Clin Respir J. 2019;13:148-158.
    Abstract    

    Abstract available

  79. KAYAPINAR O, Kaya A, Ozde C, Cebeci D, et al
    Evaluating the effect of nasal septoplasty on atrial electromechanical features.
    Am J Otolaryngol. 2019;40:179-182.
    Abstract    

    Abstract available

  80. SOKOLIUK V, DiNardo JA, Brown ML
    Never Say Never: The Use of Nitric Oxide in Patients With Obstructed Pulmonary Veins: A Case Report.
    A A Pract. 2019;12:205-207.
    Abstract    

    Abstract available

  81. FUJISAWA T, Kataoka M, Kawakami T, Isobe S, et al
    Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension.
    Circ Cardiovasc Interv. 2017;10.
    Abstract    



  82. AL-KHADRA Y, Darmoch F, Moussa Pacha H, Soud M, et al
    The Outcomes of Pulmonary Hypertension Patients With Severe Aortic Stenosis Who Underwent Surgical Aortic Valve Replacement or Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2019 May 25. pii: S0002-9149(19)30585.
    Abstract    

    Abstract available

  83. JANKOWICH M, Abbasi SA, Vang A, Choudhary G, et al
    Right Ventricular Fibrosis is Related to Pulmonary Artery Stiffness in Pulmonary Hypertension: A Cardiac Magnetic Resonance Imaging Study.
    Am J Respir Crit Care Med. 2019 May 30. doi: 10.1164/rccm.201903-0580.
    Abstract    



  84. SIMPSON CE, Hassoun PM
    Myocardial Fibrosis as a Potential Maladaptive Feature of RV Remodeling in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Jun 19. doi: 10.1164/rccm.201906-1154.
    Abstract    



  85. GAUDARD P, Barbanti C, Rozec B, Mauriat P, et al
    New Modalities for the Administration of Inhaled Nitric Oxide in Intensive Care Units After Cardiac Surgery or for Neonatal Indications: A Prospective Observational Study.
    Anesth Analg. 2018 Jan 16. doi: 10.1213/ANE.0000000000002813.
    Abstract    

    Abstract available

  86. RANCHOUX B, Nadeau V, Bourgeois A, Provencher S, et al
    Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.
    Circ Res. 2019 Jun 3. doi: 10.1161/CIRCRESAHA.118.314555.
    Abstract    

    Abstract available

  87. HADINNAPOLA C, Graf S, Morrell NW
    Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2413-2414.
    Abstract    



  88. HERNANDEZ-GONZALEZ I, Navas P, Escribano-Subias P
    Letter by Hernandez-Gonzalez et al Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2411-2412.
    Abstract    



  89. WHITE RJ, Wilkins MR
    New Therapeutic Approaches in Pulmonary Arterial Hypertension: The Pantheon Is Getting Crowded.
    Circulation. 2018;137:2390-2392.
    Abstract    



  90. KWAN WC, Shavelle DM, Laughrun DR
    Pulmonary vascular resistance index: Getting the units right and why it matters.
    Clin Cardiol. 2019;42:334-338.
    Abstract    

    Abstract available

  91. WANG W, Wen L, Song Z, Shi W, et al
    Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Clin Cardiol. 2019 Jun 12. doi: 10.1002/clc.23212.
    Abstract    

    Abstract available

  92. KING CS, Nathan SD
    Pulmonary hypertension due to interstitial lung disease.
    Curr Opin Pulm Med. 2019 Jun 18. doi: 10.1097/MCP.0000000000000599.
    Abstract    

    Abstract available

  93. MCCORMACK MC, Mathai SC
    A crossroads between the heart and lungs: air pollution and pulmonary hypertension.
    Eur Respir J. 2019;53.
    Abstract    



  94. LANG IM, Matsubara H
    Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?
    Eur Respir J. 2019;53.
    Abstract    



  95. MARON BA, Choudhary G, Tedford RJ, Brittain E, et al
    Correspondence on the debate regarding the haemodynamic definition of pulmonary hypertension.
    Eur Respir J. 2019;53.
    Abstract    



  96. GALAMBOS C, Mullen MP, Shieh JT, Schwerk N, et al
    Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension.
    Eur Respir J. 2019 May 31. pii: 13993003.01965-2018.
    Abstract    

    Abstract available

  97. BAIRD GL, Archer-Chicko C, Barr RG, Bluemke DA, et al
    Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    Abstract    

    Abstract available

  98. JAAFAR S, Visovatti S, Young A, Huang S, et al
    Impact of the Revised Hemodynamic Definition on the Diagnosis of Pulmonary Hypertension in Patients with Systemic Sclerosis.
    Eur Respir J. 2019 Jun 13. pii: 13993003.00586-2019.
    Abstract    

    Abstract available

  99. MARON BA, Wertheim BM
    Toward Early Diagnosis of Pulmonary Hypertension: Lessons From Oz.
    J Am Coll Cardiol. 2019;73:2673-2675.
    Abstract    



  100. STRANGE G, Stewart S, Celermajer DS, Prior D, et al
    Threshold of Pulmonary Hypertension Associated With Increased Mortality.
    J Am Coll Cardiol. 2019;73:2660-2672.
    Abstract    

    Abstract available

  101. SAIA F, Palazzini M, Taglieri N, Manes A, et al
    Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.
    J Am Coll Cardiol. 2017;70:2460-2461.
    Abstract    



  102. MONTERO CABEZAS JM, Nuche Berenguer J, Velazquez Martin MT, Escribano Subias P, et al
    Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.
    J Am Coll Cardiol. 2017;70:2459-2460.
    Abstract    



  103. SANTOS-LOZANO A, Fiuza-Luces C, Fernandez-Moreno D, Llavero F, et al
    Exercise Benefits in Pulmonary Hypertension.
    J Am Coll Cardiol. 2019;73:2906-2907.
    Abstract    



  104. SCHUBERT SA, Mehaffey JH, Booth A, Yarboro LT, et al
    Pulmonary-Systemic Pressure Ratio Correlates with Morbidity in Cardiac Valve Surgery.
    J Cardiothorac Vasc Anesth. 2019;33:677-682.
    Abstract    

    Abstract available

  105. DAVIS EM, Baust JJ, O'Donnell BJ, Shah FA, et al
    Correction: A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy.
    PLoS One. 2019;14:e0218401.
    Abstract    

    Abstract available

  106. RUDYK O, Rowan A, Prysyazhna O, Krasemann S, et al
    Oxidation of PKGIalpha mediates an endogenous adaptation to pulmonary hypertension.
    Proc Natl Acad Sci U S A. 2019 Jun 11. pii: 1904064116.
    Abstract    

    Abstract available

  107. CAO Y, Zhang X, Wang L, Yang Q, et al
    PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.
    Proc Natl Acad Sci U S A. 2019 Jun 18. pii: 1821401116.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;